# Screening Patients With Fabry Disease in Patients With Hypertrophic Cardiomyopathy or Left Ventricular Hypertrophy

> **NCT06169358** · — · UNKNOWN · sponsor: **Qilu Hospital of Shandong University** · enrollment: 627 (estimated)

## Conditions studied

- Hypertrophic Cardiomyopathy
- Left Ventricular Hypertrophy
- Fabry Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06169358
- **Lead sponsor:** Qilu Hospital of Shandong University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-10-01
- **Primary completion:** 2024-09-01
- **Final completion:** 2024-09-01
- **Target enrollment:** 627 (ESTIMATED)
- **Last updated:** 2023-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06169358

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06169358, "Screening Patients With Fabry Disease in Patients With Hypertrophic Cardiomyopathy or Left Ventricular Hypertrophy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06169358. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*